Vilazodone Hydrochloride
Showing 26 - 50 of 1,793
Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston
Active, not recruiting
- Metastatic Urothelial Carcinoma
- +2 more
- Doxorubicin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Oxycodone Sustained-release Tablets for Moderate to Severe
Recruiting
- Cancer Pain
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 24, 2023
Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,
Active, not recruiting
- Anorexia
- +8 more
- Anamorelin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,
Not yet recruiting
- Third Molar Extraction
- FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
- +2 more
-
São Paulo, SP, BrazilEurofarma Laboratorios S.A
Jan 11, 2023
Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)
Active, not recruiting
- Solid Neoplasm
- Laboratory Biomarker Analysis
- +2 more
-
Jacksonville, Florida
- +1 more
Jan 25, 2023
Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +2 more
- Osimertinib
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +10 more
Jan 25, 2023
Parkinson Disease Trial (Ambroxol Hydrochloride (420mg), Placebo)
Not yet recruiting
- Parkinson Disease
- Ambroxol Hydrochloride (420mg)
- Placebo
- (no location specified)
Mar 9, 2023
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick
Active, not recruiting
- Ann Arbor Stage III Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 28, 2023
Breast Reduction Trial in Rochester (Bupivacaine Hydrochloride, Liposomal Bupivacaine)
Not yet recruiting
- Breast Reduction
- Bupivacaine Hydrochloride
- Liposomal Bupivacaine
-
Rochester, MinnesotaMayo Clinic Minnesota
May 26, 2023
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 4, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,
Completed
- Adult Angiosarcoma
- +3 more
- pazopanib hydrochloride
- +4 more
-
Chicago, Illinois
- +4 more
Jul 26, 2022
ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- ADHD
- Methylphenidate Hydrochloride Extended Release Capsule
- Placebo
-
Irvine, CaliforniaUniversity of California, Irvine/Child Development Center
Nov 16, 2022
Pain Trial (Advil PM Liqui-Gels Minis, Advil PM Liqui-Gels)
Not yet recruiting
- Pain
- Advil PM Liqui-Gels Minis
- Advil PM Liqui-Gels
- (no location specified)
Jan 5, 2023
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Advanced Cancers Trial in Houston (Temsirolimus, Metformin)
Active, not recruiting
- Advanced Cancers
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
MDD Trial in Canada, United States (Vilazodone)
Completed
- Major Depressive Disorder
-
Birmingham, Alabama
- +55 more
Sep 10, 2019
DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- Mitoxantrone Hydrochloride Liposome Injection
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
May 16, 2023
Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)
Recruiting
- Interstitial Lung Diseases
- Anlotinib
- Placebo
-
Wenzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University
Apr 13, 2023
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
-
Suzhou, Jiangsu, ChinaSecond Affiliated Hospital of Soochow University
May 4, 2023